Altium Capital Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-250,000
| Closed | -$11.2M | – | 56 |
|
|
2024
Q4 | $11.2M | Buy |
250,000
+37,091
| +17% | +$1.67M | 3.19% | 8 |
|
|
2024
Q3 | $10.7M | Hold |
212,909
| – | – | 3.16% | 8 |
|
|
2024
Q2 | $8.69M | Buy |
212,909
+60,000
| +39% | +$2.45M | 3.54% | 10 |
|
|
2024
Q1 | $6.54M | Buy |
152,909
+48,000
| +46% | +$2.05M | 2.59% | 14 |
|
|
2023
Q4 | $4.22M | Buy |
104,909
+57,828
| +123% | +$2.33M | 2.87% | 14 |
|
|
2023
Q3 | $1.39M | Buy |
+47,081
| New | +$1.39M | 0.72% | 29 |
|